SCHEMBL25328987

SCHEMBL25328987

CCc1cc(OC(C)(C)C)cc(C)c1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ GABRA1 P14867 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ SHBG P04278 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ HSPA5 P11021 2/20 0.33
▸ CYP2C9 P11712 4/20 0.33
▸ CYP2C19 P33261 4/20 0.33
▸ HIF1A Q16665 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CA2 P00918 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ TYR P14679 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30356498 1.00 ESR1 (0.37) ESR1ESR2GABRA1GABRB2SHBG
SCHEMBL25328775 0.89 GABRA1 (0.46) ESR1ESR2GABRA1GABRB2MAOA
SCHEMBL14707597 0.87 SHBG (0.35) ESR1ESR2SHBGHSPA5CYP2C9
SCHEMBL13431468 0.82 CA2 (0.46) ESR1ESR2CYP2C9CYP2C19CYP2D6
SCHEMBL16546632 0.79 CYP3A4 (0.49) ESR1ESR2CYP3A4HPGDCA2
SCHEMBL25328398 0.78 NQO1 (0.38) ESR1ESR2SHBGMAOAHSD17B10
SCHEMBL30356462 0.78 NQO1 (0.38) ESR1ESR2SHBGMAOAHSD17B10
SCHEMBL14707599 0.78 SHBG (0.42) SHBGHSPA5CYP2C9CYP2C19HIF1A
SCHEMBL25328151 0.75 PTGS1 (0.50) ESR1PTGS1PTGS2THRATHRB
SCHEMBL32689520 0.75 ALDH1A1 (0.36) ESR1ESR2SHBGMAOAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583813-B2 Polymerization inhibitors BASF SE (DE) 2026-03-24 — — US disclosed
US-20230242472-A1 POLYMERIZATION INHIBITORS BASF SE (DE) 2023-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242472-A1 POLYMERIZATION INHIBITORS RCE1, CABLES1, DPYD ESR1 3959/4885ESR2 4020/4885GABRA1 3598/4885
US-12583813-B2 Polymerization inhibitors PTGS1, PTGER1, POT1 ESR1 2282/4885ESR2 1987/4885GABRA1 1980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback